Physician's Main :: Efficacy :: Bone Mineral Density

Building bone health harmoniously

Multiple studies demonstrate BMD efficacy

    • Calcitonin-salmon was shown to increase vertebral BMD by an average of 3% (95% CI: 1.8%-4.2%) from baseline†3
    • Proven to increase vertebral BMD as early as 6 months||1,5
    • Shown to sustain increases from baseline in vertebral BMD through 5 years of observation*2
    • Increased hip BMD in areas of predominantly trabecular bone¶1

HOME | PRESCRIBING INFORMATION | CORPORATE | PRIVACY POLICY | LEGAL NOTICES


IMPORTANT SAFETY INFORMATION
Indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause with low bone mass relative to healthy premenopausal women. Recommended in conjunction with adequate calcium and vitamin D intake. The most common adverse events were rhinitis, other nasal symptoms, back pain, arthralgia, epistaxis, and headache. Periodic nasal examinations are recommended; if nasal ulceration occurs, discontinue treatment until healed. Because calcitonin-salmon is a protein, the possibility of systemic allergic reaction exists. Please refer to full prescribing information.